DK1981506T6 - LONG TERM TREATMENT OF HIV INFECTION WITH TCM278 - Google Patents

LONG TERM TREATMENT OF HIV INFECTION WITH TCM278 Download PDF

Info

Publication number
DK1981506T6
DK1981506T6 DK07712053.3T DK07712053T DK1981506T6 DK 1981506 T6 DK1981506 T6 DK 1981506T6 DK 07712053 T DK07712053 T DK 07712053T DK 1981506 T6 DK1981506 T6 DK 1981506T6
Authority
DK
Denmark
Prior art keywords
tcm278
long term
hiv infection
term treatment
treatment
Prior art date
Application number
DK07712053.3T
Other languages
Danish (da)
Other versions
DK1981506T3 (en
Inventor
Lieven Elvire Colette Baert
Guenter Kraus
't Klooster Gerben Albert Eleutherius Van
Original Assignee
Janssen Sciences Ireland Unlimited Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36446113&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1981506(T6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Sciences Ireland Unlimited Co filed Critical Janssen Sciences Ireland Unlimited Co
Application granted granted Critical
Publication of DK1981506T3 publication Critical patent/DK1981506T3/en
Publication of DK1981506T6 publication Critical patent/DK1981506T6/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK07712053.3T 2006-01-20 2007-01-19 LONG TERM TREATMENT OF HIV INFECTION WITH TCM278 DK1981506T6 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06100677 2006-01-20
PCT/EP2007/050516 WO2007082922A2 (en) 2006-01-20 2007-01-19 Long term treatment of hiv- infection with tcm278

Publications (2)

Publication Number Publication Date
DK1981506T3 DK1981506T3 (en) 2013-06-24
DK1981506T6 true DK1981506T6 (en) 2021-06-14

Family

ID=36446113

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07712053.3T DK1981506T6 (en) 2006-01-20 2007-01-19 LONG TERM TREATMENT OF HIV INFECTION WITH TCM278

Country Status (28)

Country Link
US (3) US10953009B2 (en)
EP (1) EP1981506B3 (en)
JP (2) JP5754005B2 (en)
KR (2) KR101562943B1 (en)
CN (2) CN101370504A (en)
AP (1) AP2936A (en)
AR (1) AR059097A1 (en)
AU (1) AU2007206901B2 (en)
BR (1) BRPI0707179A2 (en)
CA (1) CA2636436C (en)
CY (1) CY1114089T1 (en)
DK (1) DK1981506T6 (en)
EA (1) EA014914B1 (en)
ES (1) ES2414982T7 (en)
HK (1) HK1125828A1 (en)
HR (1) HRP20130544T4 (en)
IL (1) IL192132A (en)
ME (1) ME01617B (en)
MY (1) MY150717A (en)
NZ (1) NZ569347A (en)
PL (1) PL1981506T6 (en)
PT (1) PT1981506E (en)
RS (1) RS52821B2 (en)
SG (1) SG170073A1 (en)
SI (1) SI1981506T1 (en)
TW (1) TWI458483B (en)
UA (1) UA96436C2 (en)
WO (1) WO2007082922A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
TWI457136B (en) * 2005-04-04 2014-10-21 Tibotec Pharm Ltd Prevention of hiv-infection
CL2007001847A1 (en) 2006-06-23 2008-02-08 Tibotec Pharm Ltd INTRAMUSCULAR OR SUBCUTANEOUS PHARMACEUTICAL COMPOSITION INCLUDING TMC278 (RILPIVIRINE); PROCESS TO PREPARE THE COMPOSITION; AND USE FOR THE TREATMENT OR PREVENTION OF HIV INFECTION.
AU2014200819B2 (en) * 2006-06-23 2016-05-26 Janssen Sciences Ireland Uc Aqueous suspensions of TMC278
AU2016219555B2 (en) * 2006-06-23 2017-08-10 Janssen Sciences Ireland Uc Aqueous suspensions of TMC278
AR065720A1 (en) 2007-03-14 2009-06-24 Tibotec Pharm Ltd RECONSTITUTION POWERS THAT INCLUDE RILPIVIRINE DISPERSED IN CERTAIN POLYMERS. USE. PROCESS.
MY160360A (en) * 2008-12-24 2017-02-28 Janssen Sciences Ireland Uc Implantable devices for treating hiv
MX2012003424A (en) * 2009-09-22 2012-05-08 Tibotec Pharm Ltd Treatment and prevention of hiv infection.
CA2784530C (en) 2009-12-21 2018-05-22 Janssen R&D Ireland Degradable removable implant for the sustained release of an active compound
KR20170078868A (en) 2010-01-27 2017-07-07 비이브 헬쓰케어 컴퍼니 Antibiral therapy
TWI577377B (en) 2010-09-16 2017-04-11 Ｖｉｉｖ醫療保健公司 Pharmaceutical compositions
US9266824B2 (en) 2014-01-13 2016-02-23 Warsaw Orthopedic, Inc. Methods and compositions for making an amino acid triisocyanate
SG11201804037XA (en) * 2015-11-16 2018-06-28 Evonik Roehm Gmbh Injection solution comprising a non-nucleoside reverse-transcriptase inhibitor and poly(lactide-co-glycolide)
US20190163877A1 (en) * 2017-11-27 2019-05-30 International Business Machines Corporation Decision support for effective long-term drug therapy
WO2022079739A1 (en) 2020-10-14 2022-04-21 Cipla Limited Fixed dose compositions of cabotegravir and rilpivirine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169670A (en) * 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
JO3429B1 (en) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv Hiv inhibiting pyrimidines derivatives
US6568805B1 (en) * 2001-11-26 2003-05-27 Dan L. Dietz Trust Magnetic buckle for eyeglasses
AU2003210659A1 (en) * 2002-01-24 2003-09-02 Sangstat Medical Corporation Combination therapy for treatment of hiv infection
EP1632232B3 (en) * 2004-09-02 2022-03-30 Janssen Pharmaceutica NV Salt of 4[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile
PL1632232T6 (en) * 2004-09-02 2022-06-27 Janssen Pharmaceutica Nv Salt of 4[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile
TWI457136B (en) * 2005-04-04 2014-10-21 Tibotec Pharm Ltd Prevention of hiv-infection

Also Published As

Publication number Publication date
IL192132A0 (en) 2009-08-03
AP2008004535A0 (en) 2008-08-31
BRPI0707179A2 (en) 2011-04-26
ME01617B (en) 2014-09-20
JP5754005B2 (en) 2015-07-22
EA200870183A1 (en) 2009-12-30
UA96436C2 (en) 2011-11-10
KR101562943B1 (en) 2015-10-23
KR20080085194A (en) 2008-09-23
AP2936A (en) 2014-07-31
JP5836983B2 (en) 2015-12-24
DK1981506T3 (en) 2013-06-24
SG170073A1 (en) 2011-04-29
PT1981506E (en) 2013-06-25
CY1114089T1 (en) 2016-07-27
TWI458483B (en) 2014-11-01
PL1981506T3 (en) 2013-08-30
CA2636436C (en) 2014-04-01
WO2007082922A8 (en) 2008-01-03
SI1981506T1 (en) 2013-08-30
CN101370504A (en) 2009-02-18
ES2414982T3 (en) 2013-07-23
WO2007082922A3 (en) 2007-09-20
EP1981506B1 (en) 2013-03-27
CN103877091A (en) 2014-06-25
KR101501475B1 (en) 2015-03-19
AR059097A1 (en) 2008-03-12
US20110275654A1 (en) 2011-11-10
MY150717A (en) 2014-02-28
AU2007206901A1 (en) 2007-07-26
JP2013100338A (en) 2013-05-23
HRP20130544T4 (en) 2021-08-20
WO2007082922A2 (en) 2007-07-26
EP1981506A2 (en) 2008-10-22
TW200806295A (en) 2008-02-01
NZ569347A (en) 2011-07-29
KR20140141699A (en) 2014-12-10
ES2414982T7 (en) 2021-11-05
JP2009526758A (en) 2009-07-23
CA2636436A1 (en) 2007-07-26
RS52821B (en) 2013-10-31
RS52821B2 (en) 2021-07-30
HK1125828A1 (en) 2009-08-21
US20240226099A1 (en) 2024-07-11
EP1981506B3 (en) 2021-06-09
PL1981506T6 (en) 2021-07-12
IL192132A (en) 2014-05-28
US10953009B2 (en) 2021-03-23
AU2007206901B2 (en) 2013-01-31
US20210177843A1 (en) 2021-06-17
EA014914B1 (en) 2011-02-28
HRP20130544T1 (en) 2013-07-31

Similar Documents

Publication Publication Date Title
DK1981506T6 (en) LONG TERM TREATMENT OF HIV INFECTION WITH TCM278
DK1976516T3 (en) TREATMENT OF VIRAL HEPATITIS
DK2982696T3 (en) TREATMENT OF ACUTE Lymphoblastogenic Infections
DK2084174T3 (en) Preparation of ribofuranosylpyrimidine nucleotides
DK1986633T3 (en) TREATMENT OF DUCHENNES MUSCLE DYSTROPHY
DK3494972T3 (en) Combinations of dolutegravir and lamivudine for the treatment of HIV infection
BRPI0820183A2 (en) Prevention and treatment of secondary infections after viral infection
DK2056807T3 (en) Treatment of inflammatory diseases
DK2211901T3 (en) VACCINATION WITH MULTIPLE CLADER OF H5-INFLUENZA-A-VIRUS
DK1881848T3 (en) Prevention of HIV infection with tmc278
DK2700786T3 (en) Modification of transfer passage
DK2019825T3 (en) Inhibitors of human immunodeficiency virus replication
DK2125004T3 (en) SYNERGISTIC THERAPEUTIC USE OF PROTHROMBINE COMPLEX CONCENTRATES WITH FVIII CONCENTRATES
DK2097402T3 (en) MACROCYCLIC INHIBITORS OF HEPATITIS C-VIRUS
DK1981859T3 (en) PREPARATION OF DELMOPINOL
DK2220076T5 (en) Inhibitors of the replication of human immunodeficiency virus
DK1919904T3 (en) MACROCYCLIC INHIBITORS OF HEPATITIS-C VIRUS
DK2041270T3 (en) Preparation of glycoproteins
DK2300560T3 (en) Thermal treatment of biomass
DK1732604T3 (en) Methods for treating HIV infection
BRPI0811265A2 (en) TREATMENT OF SYNUCLEINOPATHIES
DK1776136T3 (en) Treatment of conditions involving demyelination
DK1945277T3 (en) Maintaining disinfection of medical devices
DK2350116T3 (en) BIOFILM TREATMENT
DK2091673T3 (en) ELECTROMAGNETIC TREATMENT OF CONTAMINATED MATERIALS